Skip to main content Accessibility help

Thromboprophylaxis strategies for children with single-ventricle circulations (superior or total cavo-pulmonary connections) after stent implantation

  • Yinn K. Ooi (a1) (a2), R. Allen Ligon (a1) (a2), Michael Kelleman (a2), Robert N. Vincent (a1) (a2), Holly D. Bauser-Heaton (a1) (a2), Dennis W. Kim (a1) (a2) and Christopher J. Petit (a1) (a2)...



To define optimal thromboprophylaxis strategy after stent implantation in superior or total cavopulmonary connections.


Stent thrombosis is a rare complication of intravascular stenting, with a perceived higher risk in single-ventricle patients.


All patients who underwent stent implantation within superior or total cavopulmonary connections (caval vein, innominate vein, Fontan, or branch pulmonary arteries) were included. Cohort was divided into aspirin therapy alone versus advanced anticoagulation, including warfarin, enoxaparin, heparin, or clopidogrel. Primary endpoint was in-stent or downstream thrombus, and secondary endpoints included bleeding complications.


A total of 58 patients with single-ventricle circulation underwent 72 stent implantations. Of them 14 stents (19%) were implanted post-superior cavopulmonary connection and 58 (81%) post-total cavopulmonary connection. Indications for stenting included vessel/conduit stenosis (67%), external compression (18%), and thrombotic occlusion (15%). Advanced anticoagulation was prescribed for 32 (44%) patients and aspirin for 40 (56%) patients. Median follow up was 1.1 (25th–75th percentile, 0.5–2.6) years. Echocardiograms were available in 71 patients (99%), and advanced imaging in 44 patients (61%). Thrombosis was present in two patients on advanced anticoagulation (6.3%) and none noted in patients on aspirin (p = 0.187). Both patients with in-stent thrombus underwent initial stenting due to occlusive left pulmonary artery thrombus acutely post-superior cavopulmonary connection. There were seven (22%) significant bleeding complications for advanced anticoagulation and none for aspirin (p < 0.001).


Antithrombotic strategy does not appear to affect rates of in-stent thrombus in single-ventricle circulations. Aspirin alone may be sufficient for most patients undergoing stent implantation, while pre-existing thrombus may warrant advanced anticoagulation.


Corresponding author

Author for correspondence: Christopher J. Petit, MD, Emory University School of Medicine, Children’s Healthcare of Atlanta, Division of Cardiology, 1405 Clifton Road NE, Atlanta, GA 30322, USA. Tel: (404) 785-1796; Fax: (770) 488-9039; E-mail:


Hide All
1.Dasi, LP, Krishnankuttyrema, R, Kitajima, HD, et al. Fontan hemodynamics: importance of pulmonary artery diameter. J Thorac Cardiovasc Surg 2009; 137: 560564.10.1016/j.jtcvs.2008.04.036
2.Fontan, F, Kirklin, JW, Fernandez, G, et al. Outcome after a “perfect” Fontan operation. Circulation 1990; 81: 15201536.10.1161/01.CIR.81.5.1520
3.Khairy, P, Fernandes, SM, Mayer, JE Jr., et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008; 117: 8592.
4.Monagle, P, Cochrane, A, Roberts, R, et al. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol 2011; 58: 645651.10.1016/j.jacc.2011.01.061
5.Rosenthal, DN, Friedman, AH, Kleinman, CS, Kopf, GS, Rosenfeld, LE, Hellenbrand, WE. Thromboembolic complications after Fontan operations. Circulation 1995; 92: II287II293.
6.Bhole, V, Wright, JG, De Giovanni, JV, et al. Transcatheter interventions in the early postoperative period after the Fontan procedure. Catheter Cardiovasc Interv 2011; 77: 9298.10.1002/ccd.22667
7.Mets, JM, Bergersen, L, Mayer, JE Jr., Marshall, AC, McElhinney, DB. Outcomes of stent implantation for obstruction of intracardiac lateral tunnel Fontan pathways. Circ Cardiovasc Interv 2013; 6: 92100.10.1161/CIRCINTERVENTIONS.112.000099
8.Noonan, P, Kudumula, V, Anderson, B, et al. Stenting of the left pulmonary artery after palliation of hypoplastic left heart syndrome. Catheter Cardiovasc Interv 2016; 88: 225232.
9.Sreeram, N, Emmel, M, Bennink, G. Stent therapy for acute and chronic obstructions in extracardiac Fontan conduits. Cardiol Young 2013; 23: 766768.10.1017/S1047951112001886
10.Tanase, D, Ewert, P, Eicken, A. Plastic bronchitis: symptomatic improvement after pulmonary arterial stenting in four patients with Fontan circulation. Cardiol Young 2015; 25: 151153.
11.Tang, E, McElhinney, DB, Restrepo, M, Valente, AM, Yoganathan, AP. Haemodynamic impact of stent implantation for lateral tunnel Fontan stenosis: a patient-specific computational assessment. Cardiol Young 2016; 26: 116126.10.1017/S1047951114002765
12.Udink Ten Cate, FE, Trieschmann, U, Germund, I, et al. Stenting the Fontan pathway in paediatric patients with obstructed extracardiac conduits. Heart 2017; 103: 11111116.
13.Alsaied, T, Alsidawi, S, Allen, CC, Faircloth, J, Palumbo, JS, Veldtman, GR. Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis. Heart 2015; 101: 17311737.
14.Iyengar, AJ, Winlaw, DS, Galati, JC, et al. No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients. Eur J Cardiothorac Surg 2016; 50: 980987.
15.Marrone, C, Galasso, G, Piccolo, R, et al. Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis. Pediatr Cardiol 2011; 32: 3239.
16.Potter, BJ, Leong-Sit, P, Fernandes, SM, et al. Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation. Int J Cardiol 2013; 168: 39403943.10.1016/j.ijcard.2013.06.058
17.Faircloth, JM, Miner, KM, Alsaied, T, et al. Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients. J Thromb Thrombolysis 2017; 44: 3847.10.1007/s11239-017-1499-8
18.McCrindle, BW, Manlhiot, C, Cochrane, A, et al. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure. J Am Coll Cardiol 2013; 61: 346353.
19.Hirono, K, Ibuki, K, Tomita, H. Percutaneous catheter aspiration thrombectomy for the occluded stents of pulmonary artery in children with single ventricle physiology after Fontan surgery. Catheter Cardiovasc Interv 2014; 84: 11531156.
20.Schilling, C, Dalziel, K, Iyengar, AJ, d’Udekem, Y. The cost differential between warfarin versus aspirin treatment after a Fontan procedure. Heart Lung Circ 2017.10.1016/j.hlc.2017.02.003
21.Vlachojannis, GJ, Smits, PC, Hofma, SH, et al. Biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: final 5-year report from the COMPARE II trial (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent). JACC Cardiovasc Interv 2017; 10: 12151221.
22.Wiebe, J, Hoppmann, P, Colleran, R, et al. Long-term clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine practice: 2-year results of the ISAR-ABSORB registry. JACC Cardiovasc Interv 2017; 10: 12221229.10.1016/j.jcin.2017.03.029
23.Hanson, SR, Sakariassen, KS. Blood flow and antithrombotic drug effects. Am Heart J 1998; 135: S132S145.10.1016/S0002-8703(98)70241-8
24.Sakariassen, KS, Hanson, SR, Cadroy, Y. Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy. Thromb Res 2001; 104: 149174.
25.Spivack, A, Troutman, D, Dougherty, M, Calligaro, K. Changing strategies to treat venous thrombotic occlusions of the upper and lower extremities secondary to compressive phenomena. Vasc Endovascular Surg 2013; 47: 274277.
26.Lin, PH, Zhou, W, Dardik, A, et al. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 2006; 192: 782788.10.1016/j.amjsurg.2006.08.045
27.Goldenberg, NA, Branchford, B, Wang, M, Ray, C Jr., Durham, JD, Manco-Johnson, MJ. Percutaneous mechanical and pharmacomechanical thrombolysis for occlusive deep vein thrombosis of the proximal limb in adolescent subjects: findings from an institution-based prospective inception cohort study of pediatric venous thromboembolism. J Vasc Interv Radiol 2011; 22: 121132.



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed